Effect of Amritadhi Kwath In Gout

An etiopathological study of vatarakta w.s.r. To Gout And therapeutical study of amritadhi kwath

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/044300

Enrollment

Registered

2022-07-25

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M205- Other deformities of toe(s) (acquired)

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.The Patients having clinical sign & symptoms of vatarakta /gout. 2.Gout patients with uric acid level more than this normal range.(normal range 2.0 -8.5 mg/dl)

Exclusion criteria

Exclusion criteria: 1. who are suffering from uncontrolled diabetes ,joints pathologies other than arthritis . 2.Other disease such as Paralysis,parkinsons disease & cancer patients. 3.The patients having complain more than 3 year duration.

Design outcomes

Primary

Measure	Time frame
1. Improvement in sign & symptoms of vatarakta. 2.Improvement in Uric acid levelTimepoint: 2 weeks	—

Secondary

Measure	Time frame
1. Improvement in sign & symptoms of vatarakta. 2.Improvement in Uric acid levelTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Pankaj Marolia

Madan mohan Malviya Government Ayurved

pankajmarolia@gmail.com9413193101

Outcome results